Skip to main content

Medtronic plc Q1 FY2027 results

  • MDT · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$102.86+1.85%Close 13 Nov 2026 · Market value $132.0B · Next results 24 Nov 2026

Medtronic plc reported revenue of $9.76 billion, up 13.7% from a year earlier, net income of $1.47 billion and diluted earnings per share of $1.14 against $0.81 for the first quarter of fiscal 2027 (the three months to 31 Jul 2026).

From its quarterly report, the results first announced on 1 Sep 2026. Compiled and checked by AapWire.

Q1 FY2027 against Q1 FY2026

Three months to 31 Jul 2026, against the three months to 25 Jul 2025. Amounts in USD.

Medtronic plc Q1 FY2027 results against the year-ago quarter
MeasureQ1 FY2027Q1 FY2026Change
Revenue$9.76B$8.58B+13.7%
Gross profit$6.34B$5.58B+13.7%
Gross margin65.0%65.0%−0.0 pts
Operating income$1.76B$1.45B+22.1%
Operating margin18.1%16.8%+1.2 pts
Net income$1.47B$1.04B+41.3%
Diluted EPS$1.14$0.81+40.7%
Operating cash flow$1.79B$1.09B+64.8%
Capital expenditure$503.0M$504.0M−0.2%
Free cash flow$1.29B$584.0M+121%

Operating KPIs for the quarter

Medtronic plc operating KPIs, Q1 FY2027
KPIQ1 FY2027Change on a year
Electrophysiology Therapies revenue$2.2Bup 29.6%
Surgical & Endoscopy revenue$1.7Bup 8.7%
Cranial & Spinal Technologies revenue$1.4Bup 12.7%
Specialty Therapies revenue$774.0Mup 10.3%
Acute Care & Monitoring revenue$539.0Mup 14.4%
Neuromodulation revenue$539.0Mup 4.9%
Reportable segment net sales$8.9Bup 14.1%
Cardiovascular revenue$3.9Bup 19.5%
Neuroscience revenue$2.7Bup 10.3%
Medical Surgical revenue$2.3Bup 9.9%
Diabetes revenue$843.0Mup 16.9%
United States revenue$4.9Bup 16.1%
International revenue$4.9Bup 11.4%
Rest of world revenue$4.8Bup 11.3%
Ireland revenue$40.0Mup 21.2%

Earlier quarters

Medtronic plc results, last eight filed quarters
QuarterPeriod endRevenueChange on a yearDiluted EPS
Q1 FY202731 Jul 2026$9.76B+13.7%$1.14
Q4 FY202624 Apr 2026$9.81B+9.9%$0.97
Q3 FY202623 Jan 2026$9.02B+8.7%$0.89
Q2 FY202624 Oct 2025$8.96B+6.6%$1.07
Q1 FY202625 Jul 2025$8.58B+8.4%$0.81
Q4 FY202525 Apr 2025$8.93B+3.9%$0.82
Q3 FY202524 Jan 2025$8.29B+2.5%$1.01
Q2 FY202525 Oct 2024$8.40B+5.2%$0.99

More on Medtronic plc: financial statements · revenue · earnings per share

MDT's results, as they are filed.

Releases read within minutes, guidance against results, the quarter in its eight-quarter history, and an alert on each new report.